Comparison of corneal flap thickness predictability and architecture between femtosecond laser and sub-Bowman keratomileusis microkeratome in laser in situ keratomileusis.

Autor: Rattan, Suzan Amana, Rashid, Riyam Faihan, Mutashar, Mahir Kadhim, Nasser, Yaser A. R., Anwar, Didar S.
Zdroj: International Ophthalmology; May2023, Vol. 43 Issue 5, p1553-1558, 6p
Abstrakt: Purpose of the study: The purpose of the study is to assess and compare the corneal flap thickness predictability and uniformity between Visumax femtosecond laser and Moria sub-Bowman keratomileusis microkeratome in laser in situ keratomileusis procedure to correct myopic and myopic astigmatism refractive errors. Methods: One hundred eyes from 100 patients were enrolled in this study. Only one eye (right eye) of each patient was chosen for this study. They were divided into two groups of equal size (50 each). Target flap thickness was 90 μm. Flap thickness was measured by anterior segment optical coherence tomography in 7 specified positions at 3 months postoperative. Results: For femtosecond laser group, the average central flap thickness (CFT) was 91.35 µm ± 4.97. There was no statistically significant difference between the target flap thickness and the resultant flap thickness (p = 0.12). When the central, nasal and temporal thicknesses in the same flap were compared, there was no statistically significant difference among these measurements (p = 0.9). For the microkeratome group, CFT was 102.18 µm ± 5.63. There was statistically significant difference between the target flap thickness and the resultant flap thickness (p = 0.001). The central, nasal and temporal thicknesses were compared and there was a statistically significant difference (p = 0.000). Conclusions: Our study is among few studies in the literature comparing femtosecond laser flap to SBK microkeratome flap. Femtosecond laser creates more predictable flap thickness and more uniform flap architecture. Trial registration Trial registration number: NCT04684888. Trial Registration date: December 2020. Registered at www.clinicaltrials.gov. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index
Externí odkaz: